Akebia Therapeutics AKBA
NASDAQ AKBA
$0.59 -0.03 (-5.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) EV to EBITDA (2024 - 2026)

Updated

Akebia Therapeutics' (AKBA) EV to EBITDA stood at 31.91 in Q1 2026, down 47.5% from 60.78 a year earlier but up 226.0% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) EV to EBITDA (2024 - 2026) Analysis & Trends

On a TTM basis, Akebia Therapeutics' EV to EBITDA came in at -42.43 as of Mar 31, 2026; for FY2025, it came in at 9.79.

  • Quarterly EV to EBITDA has ranged from 9.79 in Q4 2025 to 172.55 in Q1 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 9.79 (Q4 2025), 19.89 (Q3 2025) and 40.75 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Akebia Therapeutics 157.80 Mn -511.68 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 31.91
Dec 31, 2025 9.79
Sep 30, 2025 19.89
Jun 30, 2025 40.75
Mar 31, 2025 60.78
Sep 30, 2024 89.17
Jun 30, 2024 77.54
Mar 31, 2024 172.55
API Access

Akebia Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AKBA&period=max&api_key=YOUR_API_KEY